How effective is Micardis for Hypotension? (a real world drug study)

Summary:

Overall ratings: 3.5/5
Long term ratings: 3.5/5

This is a phase IV clinical study of how effective Micardis (telmisartan) is for Hypotension and for what kind of people. The study is created by eHealthMe from 4 Micardis users and is updated continuously.

What is Micardis?

Micardis has active ingredients of telmisartan. It is often used in high blood pressure. eHealthMe is studying from 27,605 Micardis users. Check the latest studies of Micardis.

What is Hypotension?

Hypotension (abnormally low blood pressure) is found to be associated with 3,354 drugs and 4,759 conditions by eHealthMe. Check the latest studies of Hypotension.


On Jul, 05, 2026

4 people are studied for taking Micardis in Hypotension

Overall effectiveness (number of people):

Does Micardis work for your Hypotension (overall)?

Long term (1+ years) effectiveness (number of people):

Does Micardis work for your Hypotension (long term)?

Micardis effectiveness for Hypotension (number of people):

Overall:
  • not at all: 0
  • somewhat: 0
  • moderate: 2
  • high: 2
  • very high: 0
Long Term:
  • not at all: 0
  • somewhat: 0
  • moderate: 1
  • high: 1
  • very high: 0

Gender of people who take Micardis for Hypotension *:

  • female: 50 %
  • male: 50 %

Age of people who take Micardis for Hypotension *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 50 %
  • 60+: 50 %

Who find Micardis more effective for Hypotension?

Gender of people who take Micardis for Hypotension *:

  • female: 50 %
  • male: 50 %

Age of people who take Micardis for Hypotension *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 100 %
  • 60+: 0.0 %

* Approximation only. Some reports may have incomplete information.

Do you take Micardis?

- You can start a phase IV clinical trial to monitor Micardis safety and effectiveness.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Alternative drugs to, pros and cons of:

Treatments, associated drugs and conditions:

How the study uses the data?

The study is based on telmisartan (the active ingredients of Micardis) and Micardis (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: